Multi-center transferability of a breath-hold T2 technique for myocardial iron assessment

Journal of Cardiovascular Magnetic Resonance

Volumn 10, Issue 1, 2008, Pages

  He, Taigang ^a,b   Kirk, Paul ^a,b   Firmin, David N ^a,b   Lam, Wynnie M ^c   Chu, Winnie C W ^c   Au, Wing Yan ^d   Chan, Godfrey C F ^d   Tan, Ru San ^e   Ng, Ivy ^f   Biceroglu, Selen ^g   Aydinok, Yesim ^g   Fogel, Mark A ^h   Cohen, Alan R ^h   Pennell, Dudley J ^a,b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

^e DEPARTMENT OF CARDIOLOGY   (Singapore)

^f KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

^g EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^h CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE; IRON;

ADULT; ARTICLE; BLOOD; BREATH HOLDING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DIAGNOSTIC VALUE; HEART MUSCLE; HUMAN; IRON OVERLOAD; MEDICAL INSTRUMENTATION; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; REPRODUCIBILITY; THALASSEMIA; UNITED KINGDOM; VALIDATION STUDY; BETA THALASSEMIA; BREATHING; CLINICAL TRIAL; HONG KONG; INSTRUMENTATION; METABOLISM; METHODOLOGY; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; SINGAPORE; TURKEY (REPUBLIC); UNITED STATES;

ADULT; BETA-THALASSEMIA; HONG KONG; HUMANS; IRON; LONDON; MAGNETIC RESONANCE IMAGING; MYOCARDIUM; OBSERVER VARIATION; PHILADELPHIA; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RESPIRATION; SINGAPORE; TURKEY;

EID: 44049090531     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-10-11     Document Type: Article

References (19)

1. Tanner MA, Galanello R, Dessi C, Westwood MA, Smith GC, Nair SV, Anderson LJ, Walker JM, Pennell DJ: Myocardial iron loading in patients with thalassemia major on deferoxamine chelation. J Cardiovasc Magn Reson 2006, 8: 543-547.
2. Maceira AM, Prasad SK, Khan M, Pennell DJ: Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2006, 8: 417-526.
3. Olivieri NF, Nathan DG, MacMillan JH, Wayne AS, Liu PP, McGee A, Martin M, Koren G, Cohen AR: Survival in medically treated patients with homozygous beta-thalassemia. N Engl J Med 1994, 331: 574-578. (Pubitemid 24265699)
4. Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, Romeo MA, Forni GL, Gamberini MR, Ghilardi R, Piga A, Cnaan A: Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 2004, 89: 1187-1193. (Pubitemid 39390442)
5. Tanner MA, Porter JB, Westwood MA, Nair SV, Anderson LJ, Walker JM, Pennell DJ: Myocardial T2* in patients with cardiac failure secondary to iron overload. Blood 2005, 106(Suppl): 40B. (Abstract 3838a)
6. Wood JC, Tyszka JM, Carson S, Nelson MD, Coates TD: Myocardial iron loading in transfusion- dependent thalassemia and sickle cell disease. Blood 2004, 103: 1934-1936. (Pubitemid 38268994)
7. Anderson LJ, Wonke B, Prescott E, Holden S, Walker JM, Pennell DJ: Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron levels and ventricular function in beta thalassemia. Lancet 2002, 360: 516-520. (Pubitemid 35232104)
8. Anderson LJ, Westwood MA, Holden S, Davis B, Prescott E, Wonke B, Porter JB, Walker JM, Pennell DJ: Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: A prospective study using T2* cardiovascular magnetic resonance. Br J Haematol 2004, 127: 348-355. (Pubitemid 39468951)
9. Pennell DJ, Berdoukas V, Karagiorga M, Ladis V, Piga A, Aessopos A, Gotsis ED, Tanner MA, Smith GC, Westwood MA, Wonke B, Galanello R: Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis. Blood 2006, 107: 3738-3744.
10. Tanner MA, Galanello R, Dessi C, Smith GC, Westwood MA, Agus A, Roughton M, Assomull R, Nair SV, Walker JM, Pennell DJ: A randomized, placebo controlled, double blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance. Circulation 2007, 115: 1876-1884. (Pubitemid 46598901)
11. Wood JC: Magnetic resonance imaging measurement of iron overload. Curr Opin Hematol 2007, 14: 183-190. (Pubitemid 46597601)
12. Westwood MA, Anderson LJ, Firmin DN, Gatehouse PD, Lorenz CH, Wonke B, Pennell DJ: Interscanner reproducibility of cardiovascular magnetic resonance T2* measurements of tissue iron in thalassemia. J Magn Reson Imaging 2003, 18: 616-620. (Pubitemid 37345172)
13. Westwood MA, Firmin DN, Gildo M, Renzo G, Stathis G, Markissia K, Vasili B, Pennell DJ: Intercenter reproducibility of magnetic resonance T2* measurements of myocardial iron in thalassaemia. Int J Cardiovasc Imaging 2005, 21: 531-538. (Pubitemid 41435154)
14. Tanner MA, He T, Westwood MA, Firmin DN, Pennell DJ, Thalassemia International Federation Heart T2* Investigators: Multicenter validation of the transferability of the magnetic resonance T2* technique for the quantification of tissue iron. Haematologica 2006, 91: 1388-1391.
15. Mavrogeni SI, Gotsis ED, Markussis V, Tsekos N, Politis C, Vretou E, Kermastinos D: T2 relaxation time study of iron overload in B-thalassemia. MAGMA 1998, 6: 7-12. (Pubitemid 28500263)
16. Papanikolaou N, Ghiatas A, Kattamis A, Ladis C, Kritikos N, Kattamis C: Non-invasive myocardial iron assessment in thalassaemic patients. T2 relaxometry and magnetization transfer ratio measurements. Acta Radiol 2000, 41: 348-351.
17. Ghugre NR, Enriquez CM, Gonzalez I, Nelson MD Jr, Coates TD, Wood JC: MRI detects myocardial iron in the human heart. Magn Reson Med 2006, 56: 681-686. (Pubitemid 44338890)
18. Wood JC, Otto-Duessel M, Aguilar M, Nick H, Nelson MD, Coates TD, Pollack H, Moats R: Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy. Circulation 2005, 112: 535-543. (Pubitemid 41060794)
19. He T, Gatehouse PD, Anderson LJ, Tanner M, Keegan J, Pennell DJ, Firmin DN: Development of a novel optimized breathhold technique for myocardial T2 measurement in thalassemia. J Magn Reson Imaging 2006, 24: 580-585. (Pubitemid 44320560)